Takasago International (TYO:4914) sold all 444,038 shares it held in Hisamitsu Pharmaceutical (TYO:4530) through a tender offer by Taiyo Kosan, which closed Feb. 19, according to a Tuesday filing on the Tokyo Stock Exchange.
The shares were sold at 6,082 yen each for 2,700 million yen, with settlement set for Feb. 27.
Takasago expects to record a 2.54 billion yen gain on the sale of investment securities as extraordinary income in the fiscal year ending March 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.